Stephen Naymick, DO
Family Medicine · Camp Lejeune, NCNPI 1609298009
Payments from drug & device makers
Across 24 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$88
- Lundbeck LLC$76
- Tolmar, Inc.$62
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$29
- AstraZeneca$25
- Neurocrine Biosciences, Inc.$20
- plus $136 from 9 others
What the payments were for
- Food & beverage$436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 5 | $88 |
| Lundbeck LLC | 3 | $76 |
| Tolmar, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| AstraZeneca | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| CSL Behring | 1 | $16 |
| Organon | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Vertex | 1 | $15 |
| Amgen | 1 | $14 |
| Medtronic | 1 | $14 |
| Pfizer | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$436 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $24,027 |
| Gabapentin | 33 | $573 |
| Rosuvastatin Calcium | 23 | $322 |
| Atorvastatin Calcium | 28 | $309 |
| Azelastine Hcl | 16 | $306 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $297 |
| Fluticasone Propionate | 18 | $246 |
| Losartan Potassium | 36 | $233 |
| Levothyroxine Sodium | 24 | $212 |
| Amlodipine Besylate | 30 | $177 |
| Trazodone Hcl | 26 | $176 |
| Alendronate Sodium | 17 | $174 |
| Lisinopril | 28 | $144 |
| Sertraline Hcl | 21 | $134 |
| Omeprazole | 20 | $132 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Camp Lejeune
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.